Medtech fundings for March 2017 stand at $576 million, led by the $59 million IPO of Symetics, the $50 million Series C funding of Moximed, the $45 million funding of Corindus, the $40 million funding round of VertiFlex, and the $38 million funding of pig-to-human xenotransplant company eGenesis.
The complete list of fundings in medtech for March 2017 thus far are shown at link. Below are the top fundings for the month.
Source: Compiled by MedMarket Diligence, LLC
For a historical list of fundings by month since 2009, see link.